The 2026 Nobel Prize in Physiology or Medicine has been awarded to Peter Hegemann, Georg Nagel and Karl Deisseroth for their work that led to optogenetics, a technique that allows scientists to control and study nerve-cell activity using light.
The method has transformed neuroscience by giving researchers a way to investigate how specific groups of nerve cells contribute to memories, emotions and behaviour in living brains. The Nobel Committee said the laureates’ discoveries have helped establish new ways of studying the functioning of the brain.
The work began with research into a single-celled alga called Chlamydomonas. Hegemann was interested in understanding how the organism detects light and moves towards a light source. In the early 2000s, Hegemann and Nagel identified channelrhodopsin, a protein located on the surface of the algal cell.
Channelrhodopsin has a distinctive property: when exposed to blue light, it opens a channel that allows charged ions to pass through the cell membrane. This creates an electrical signal. The researchers found that introducing the protein into other types of cells could make those cells responsive to light.
This discovery provided the key component needed to develop a new method for manipulating electrical activity in nerve cells.
Deisseroth subsequently introduced the gene responsible for channelrhodopsin into neurons taken from rats. When the modified nerve cells were exposed to blue light, their activity could be triggered. He reported this breakthrough in 2005.
The technique was taken a major step further in 2007, when Deisseroth demonstrated that light could be used to control genetically modified nerve cells inside the brains of living mice.
The approach became known as optogenetics, combining genetic techniques with the use of light to control specific cells. Unlike earlier methods that often made it difficult to determine whether a particular brain region was directly responsible for a behaviour or function, optogenetics enabled researchers to manipulate selected neural circuits and observe the resulting effects.
The development has helped scientists investigate the neural pathways associated with a range of brain functions. Researchers have used the technique to study circuits involved in memories, emotions and behaviours, including processes relevant to neurological and psychiatric conditions.
The Nobel Committee described optogenetics as providing new opportunities to map the brain and understand relationships between neural activity and behaviour. According to Per Svenningsson, Chair of the Nobel Committee for Physiology or Medicine, the technique provides opportunities for mapping the brain that researchers could previously only have imagined.
The significance of optogenetics extends beyond basic neuroscience. Researchers are also investigating possible medical applications of the technology. One area of research involves using optogenetic approaches in attempts to restore vision in people with visual impairment.
The development of the technique represents a shift in how scientists can study the brain. Rather than only observing which areas become active during a particular process, researchers can manipulate selected neural pathways and examine the consequences.
The discoveries recognised by the 2026 Nobel Prize therefore connect fundamental biological research with a technology that has become an important tool in modern neuroscience. The work of Hegemann and Nagel in identifying channelrhodopsin provided the molecular foundation, while Deisseroth’s experiments demonstrated how the protein could be used as a light-controlled switch in nerve cells and eventually in living brains.
The Nobel recognition highlights the continuing effort to understand how billions of interconnected nerve cells produce complex functions such as memory, emotion and behaviour. Optogenetics has given researchers a more precise way to investigate these relationships and continues to shape research into the workings of the living brain.
